טוען...
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
Brain autopsy and biomarker studies indicate that the pathology of Alzheimer’s disease (AD) is initiated at least 10–20 years before clinical symptoms. This provides a window of opportunity to initiate preventive treatment. However, this emphasizes the necessity for biomarkers that identify individu...
שמור ב:
| הוצא לאור ב: | Transl Psychiatry |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5545720/ https://ncbi.nlm.nih.gov/pubmed/28072416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tp.2016.252 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|